Advanced search
Publication Cover
Psychology Research and Behavior Management Volume 10, 2017 - Issue
Submit an article Journal homepage
82
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Evaluation of sleep profile in schizophrenia patients treated with extended-release paliperidone: an open-label prospective study in Southeast Asia

Ronnachai Kongsakon1 Department of Psychiatry, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, ThailandCorrespondence[email protected]
,
Nuntika Thavichachart2 Department of Medicine, Division of Psychiatry, King Chulalongkorn Memorial Hospital, Chulalongkorn University, Bangkok, Thailand
,
Ka Fai Chung3 Department of Psychiatry, University of Hong Kong, Hong Kong, People’s Republic of China
,
Leslie Lim4 Department of Psychiatry, Singapore General Hospital, Singapore
,
Beverly Azucena5 National Center for Mental Health, Mandaluyong, Philippines
,
Elizabeth Rondain6 Makati Medical Center, Makati, Philippines
,
Benson Go7 Northern Mindanao Medical Center, Cagayan De Oro, Misamis Oriental, Philippines
,
Fe Costales8 Perpetual Succour Hospital, Cebu, Philippines
&
Osot Nerapusee9 Medical Affairs, Janssen-Cilag, Bangkok, Thailand
 show all
Pages 323-327 | Published online: 27 Oct 2017

References

  • MillerDDAtypical antipsychotics: sleep, sedation and efficacyJ Clin Psychiatry2004637
  • MontiJMMontiDSleep disturbance in schizophreniaInt Rev Psychiatry200517424725316194796
  • CohrsSSleep disturbance in patients with schizophrenia: Impact and effect of antipsychoticCNS Drug20062211939962
  • MarderSRKramerMFordLEfficacy and safety of paliperidone extended release tablets: results of a 6-week, randomized, placebo-controlled studyBiol Psychiatry20076213631367017601495
  • DavidsonMEmsleyRKramerMEfficacy, safety and effect on functioning of paliperidone extended-release tablets in the treatment of acute schizophrenia: an international 6-week placebo-controlled studySchizophrenia Res200793117130
  • KaneJCanasFKramerMTreatment of schizophrenia with paliperidone extended-release tablets: a 6-week placebo-controlled trialSchizophrenia Res200790147161
  • MeltzerHKramerMGassmann-MayerCEfficacy and tolerability of oral paliperidone extended-release tablets in the treatment of acute schizophrenia: pooled data from three 6-week placebo-controlled studiesInt J Neuropsychopharmacol20069S225
  • KramerMKushnerSVijapurkarUDelaying symptom recurrence in patients with schizophrenia with paliperidone extended-release tablet: an international, randomized, double-blind, placebo-controlled studyPresented at the Collegium Internationale Neuro-PsychopharmacologicumJuly 9–13; 2006Chicago, IL
  • LuthringerRStanerLNoelNA double-blind, placebo-controlled, randomized study evaluating effect of paliperidone extended-release tablets on sleep architecture in patients with schizophreniaInt Clin Psychopharmacol20072229930817690599
  • JanicakPWinansEPaliperidoneERA review of the clinical trial dataNeuropsychiatric Disease Treatment20073686988319300622
  • ThavichachartNKongsakonRLoWTThe psychopathological characteristics of treatment discontinuation group in 6-month treatment with paliperidone ERInt J Clin Pract2012661096997522994331
  • BirnbaumMSharifZMedication adherence in schizophrenia: patient perspectives and the clinical utility of paliperidone ERPatient Prefer Adherence2008223324019920968
  • ChanMSChungKFYungKPYeungWFSleep in schizophrenia: A systematic review and meta-analysis of polysomnographic findings in case-control studiesSleep Med Rev201732698427061476

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.